[October 20, 2014]

Research and Markets: Global Ebola Virus Vaccine Market & Pipeline Insight Report 2014 - Analysis of 26 Clinical Trials & 15 in Preclinical Phase

Research and Markets (http://www.researchandmarkets.com/research/bb5lvl/ebola_virus) has announced the addition of the "Ebola Virus Vaccine Market & Pipeline Insight" report to their offering.

In terms of treatment, till date, there is not standard treatment method for Ebola hemorrhagic fever. Only supportive therapy is available. Also, there is no licensed vaccine for Ebola virus infection which is of clinical use. The researchers have been trying to better understand this virus and target its ecological reservoirs in order to get a deeper understanding of the cause and nature of the outbreaks of this disease. There are currently many experiments in the laboratories which are focusing on developing an appropriate vaccine for the prevention of this disease, but no success has been met till now.

The pharma companies have a significant opportunity in the field of Ebola virus infections in terms of developing drugs, vaccines and introducing meaures to control and prevent the spread of the disease. After the success of the clinical candidates, and the market approval of these drugs or vaccines, it is most likely that there could a significant demand for these products from the physicians and patients. Additionally, due to the nature of the disease, these products would be priced at a premium, which would eventually yield high revenues for the companies which would earn a significant return on investment.

Ebola Virus Vaccine Market & Pipeline Insight Report Highlight:

• Ebola Virus Infection Market Overview
• Ebola Vaccine Clinical Trial Insight by Phase, Company & Country
• Ebola Vaccine in Clinical Trials: 26 Vaccine
• Majority Ebola Vaccine in Preclinical Phase: 15 Vaccines
• Ebola Vaccines by Mechanism of Action, Drug Class, Route of administration, Patent Analysis & Licensing Status

Key Topics Covered:

1. Ebola Virus Infection Market Overview

• Symptoms & Diagnostics
• Causes of Ebola Virus Infection
• Incidence
• Ongoing developments
• Future Scenario

2. Ebola Vaccine Clinical Trial Overview

3. Ebola Vaccine Clinical Trial Insight by Phase, Company & Country

• Research
• Preclinical
• Clinical
• Phase-I

4. Suspended & Discontinued Ebola Vaccine Clinical Trial Insight by Phase, Company & Country

• No Development Reported
• Discontinued
• Suspended

5. Competitive Landscape

• Bavarian Nordic
• Crucell
• Fab Entech
• Inovio Pharmaceuticals
• Microbiotix
• Mitsubishi (News - Alert) Tanabe Pharma
• Profectus Biosciences
• SIGA Technologies
• Tekmira Pharmaceuticals
• Vaxart

For more information visit http://www.researchandmarkets.com/research/bb5lvl/ebola_virus

[ Back To TMCnet.com's Homepage ]